Biogen partner calls for global Alzheimer's effort
Global action must be taken in the battle against Alzheimer's according to Biogen's Japanese collaborative partner Eisai, following the US pharmaceutical company's recent drug approval in the US.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Biogen's Japanese collaborative partner Eisai is calling for global action in the battle against Alzheimer's, which the partner refers to as a "secret pandemic," according to the Financial Times.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA advisors quit after approval of Alzheimer's medicine
For subscribers
Biogen to start shipping new Alzheimer's drug in two weeks
For subscribers
Sage Therapeutics depression drug disappoints
For subscribers
